Article
The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association - 1 May 2006
Hermans M P, Gala J-L, Buysschaert M
Abstract excerpt
OBJECTIVE: Individuals with Type 2 diabetes are at increased risk of stroke. Plasma homocysteine (tHcy) is an independent risk factor for cardiovascular (CV) disease. The methylene-tetrahydrofolate reductase (MTHFR) gene polymorphism (thermolabile variant C(677)T) is associated with CV risk, partly as a result of increased Hcy, especially in homozygous subjects. AIM: To relate the occurrence of the MTHFR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
